Berkshire Hathaway was briefly a member of the group, but its market cap has dipped slightly below the threshold this month.
A breast cancer diagnosis is almost always followed by invasive biopsies, surgery, radiotherapy, chemotherapy and hormone ...
The Food and Drug Administration (FDA) has recently approved an innovative obesity medication from Eli Lilly that hold ...
The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in ...
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
Eli Lilly and Company (NYSE:LLY – Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $757.54, but opened at $811.35. Eli Lilly and Company shares ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Zepbound and the diabetes treatment Mounjaro (which are the same underlying drug), as well as other products, such as its recently approved Alzheimer's disease treatment, Kisunla, should help drive ...
Dubai Customs reported record-breaking passenger numbers as cruise tourism thrives at Port Rashid and Dubai Harbor.